Cargando…

The disposition of cytotoxic agents after intralymphatic infusion.

Detalles Bibliográficos
Autores principales:	Calnan, J. S., Rivero, O. R., Reis, N. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1967
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008109/ https://www.ncbi.nlm.nih.gov/pubmed/6028084

Ejemplares similares

Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015)

Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022)

Intralymphatic Histiocytosis: An Unusual Presentation
por: Blackwell, Timothy J., et al.
Publicado: (2021)

The Transplantability of Tumours by Intravenous and Intralymphatic Routes
por: Wallace, A. C., et al.
Publicado: (1965)

Papillary intralymphatic angioendothelioma: Dabska tumor()()
por: Silva, Thadeu Santos, et al.
Publicado: (2020)

Papillary intralymphatic angioendothelioma: An extremely rare tumor
por: Kaplan, Güven Ozan, et al.
Publicado: (2021)

Allergen-specific intralymphatic immunotherapy in human and animal studies
por: Kim, Seon Tae, et al.
Publicado: (2017)

Intralymphatic Histiocytosis Associated with Osteoarthritis: A Case Report
por: Koo, Taehan, et al.
Publicado: (2022)

Alteration of tissue disposition of cadmium by chelating agents.
por: Klaassen, C D, et al.
Publicado: (1984)

Analytical approaches to the study of the disposition of myelotoxic agents.
por: Rickert, D E, et al.
Publicado: (1981)

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
por: Radomski, Michal, et al.
Publicado: (2016)

Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
por: Jiang, Sijie, et al.
Publicado: (2023)

Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial
por: Hylander, Terese, et al.
Publicado: (2016)

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
por: Park, Hye Jung, et al.
Publicado: (2021)

Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literature
por: Gambarotti, Marco, et al.
Publicado: (2018)

Intralymphatic Immunotherapy Alleviates Allergic Symptoms During Allergen Exposure in Daily Life
por: Lee, Sang Pyo, et al.
Publicado: (2018)

Intralymphatic Histiocytosis with Massive Interstitial Granulomatous Foci in a Patient with Rheumatoid Arthritis
por: Tanaka, Mayuri, et al.
Publicado: (2017)

Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma
por: Kirita, Keisuke, et al.
Publicado: (2013)

Locally Invasive Papillary Intralymphatic Angioendothelioma Arising Within a Lymphatic/Venous Malformation
por: Al-Refai, Reham, et al.
Publicado: (2023)

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen- a randomized controlled trial
por: Hellkvist, Laila, et al.
Publicado: (2015)

Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome
por: Kim, Tae Beom, et al.
Publicado: (2018)

Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report
por: Sugano, Teppei, et al.
Publicado: (2019)

A Pilot Study of Intralymphatic Immunotherapy for House Dust Mite, Cat, and Dog Allergies
por: Lee, Sang Pyo, et al.
Publicado: (2017)

Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis
por: Aini, Nor Rahimah, et al.
Publicado: (2021)

Intralymphatic histiocytosis of the upper eyelid in a patient of Korean descent: A case report
por: Ha, Dong Hee, et al.
Publicado: (2023)

The History, Use, Disposition and Environmental Fate of Agent Orange
por: Stellman, Jeanne M., et al.
Publicado: (2010)

Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the Severity of Collagen-Induced Experimental Arthritis
por: Mancheño-Corvo, Pablo, et al.
Publicado: (2017)

Benign Atypical Intralymphatic CD30+ T-Cell Proliferation: A Case Report and Literature Review
por: Jang, Nu Ri, et al.
Publicado: (2019)

DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling
por: Tal, Orna, et al.
Publicado: (2011)

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours
por: Bialkowski, Lukasz, et al.
Publicado: (2016)

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
por: Nowak, Christoph, et al.
Publicado: (2022)

Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up
por: Adlany, Yasmin K., et al.
Publicado: (2022)

Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study
por: Schmid, Johannes Martin, et al.
Publicado: (2016)

Dispositions : a debate /
por: Armstrong, D. M. (David Malet), 1926-
Publicado: (1996)

Strong ERG Positivity in Papillary Intralymphatic Angioendothelioma of the Testis of a 24-Year-Old Male: A Case Report
por: Schultheis, Anne M., et al.
Publicado: (2013)

Unusual multifocal intraosseous papillary intralymphatic angioendothelioma (Dabska tumor) of facial bones: a case report and review of literature
por: LI, Bin, et al.
Publicado: (2013)

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans
por: Chabot, Alexandra, et al.
Publicado: (2022)

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
por: Weinfeld, Dan, et al.
Publicado: (2020)

Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
por: Ahlbeck, Lars, et al.
Publicado: (2022)

SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours
por: Khatri, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qe0dlafu27ku3ju90etajgmgo5